TOCQUEVILLE ASSET MANAGEMENT L.P. - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 108 filers reported holding INOVIO PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.68 and the average weighting 0.0%.

Quarter-by-quarter ownership
TOCQUEVILLE ASSET MANAGEMENT L.P. ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2020$216,000
+9.6%
8,000
-69.8%
0.01%0.0%
Q1 2020$197,000
+28.8%
26,500
-42.8%
0.01%
+150.0%
Q4 2019$153,000
+33.0%
46,300
-17.8%
0.00%0.0%
Q3 2019$115,000
-46.0%
56,300
-22.1%
0.00%
-33.3%
Q2 2019$213,000
-5.3%
72,300
+19.9%
0.00%0.0%
Q1 2019$225,000
+94.0%
60,300
+104.4%
0.00%
+200.0%
Q2 2018$116,000
-16.5%
29,5000.0%0.00%
-50.0%
Q1 2018$139,000
-36.2%
29,500
-44.2%
0.00%0.0%
Q4 2017$218,000
+49.3%
52,900
+151.9%
0.00%0.0%
Q4 2016$146,000
-43.0%
21,000
-23.6%
0.00%
-33.3%
Q3 2016$256,000
-80.7%
27,500
-80.8%
0.00%
-62.5%
Q2 2016$1,324,000
+116.0%
143,200
+103.4%
0.01%0.0%
Q1 2016$613,000
+34.4%
70,400
+3.8%
0.01%
+33.3%
Q4 2015$456,000
+51.0%
67,800
+29.6%
0.01%
+50.0%
Q3 2015$302,000
-33.6%
52,300
-6.3%
0.00%
-20.0%
Q2 2015$455,000
+35.8%
55,800
+36.1%
0.01%
+25.0%
Q1 2015$335,000
-20.6%
41,000
-10.9%
0.00%
-20.0%
Q4 2014$422,000
-24.8%
46,000
-19.3%
0.01%
-16.7%
Q3 2014$561,000
+155.0%
57,000
+179.8%
0.01%
+200.0%
Q2 2014$220,00020,3750.00%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q1 2017
NameSharesValueWeighting ↓
Triatomic Management LP 235,000$405,0000.23%
Green Alpha Advisors, LLC 147,380$254,0000.22%
Financial Advocates Investment Management 14,161$628,0000.05%
Virtus ETF Advisers LLC 72,540$125,0000.05%
Cedar Brook Financial Partners, LLC 88,750$153,0940.05%
Rafferty Asset Management, LLC 2,363,189$4,077,0000.04%
Hennion & Walsh Asset Management, Inc. 352,721$608,0000.04%
CAXTON ASSOCIATES LP 130,728$226,0000.03%
Keystone Financial Group 74,058$128,0000.03%
Virtu Financial LLC 130,829$226,0000.02%
View complete list of INOVIO PHARMACEUTICALS INC shareholders